L U C13 (Perindopril erbumine 8 mg)
Pill imprint L U C13 has been identified as Perindopril erbumine 8 mg.
Perindopril is used in the treatment of high blood pressure; diabetic kidney disease; coronary artery disease; heart failure; left ventricular dysfunction (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Perindopril 8 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- L U C13
- Strength:
- 8 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Lupin Pharmaceuticals, Inc
- National Drug Code (NDC):
- 68180-0237
- Inactive Ingredients:
- silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
More about perindopril
Consumer resources
- Other brands: Aceon
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
